136 related articles for article (PubMed ID: 8912374)
1. Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters.
Nahum AE
Phys Med Biol; 1996 Oct; 41(10):1957-72. PubMed ID: 8912374
[TBL] [Abstract][Full Text] [Related]
2. The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y.
Wheldon TE; O'Donoghue JA; Barrett A; Michalowski AS
Radiother Oncol; 1991 Jun; 21(2):91-9. PubMed ID: 1866470
[TBL] [Abstract][Full Text] [Related]
3. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a 32P/33P radionuclide cocktail.
Lechner A; Blaickner M; Gianolini S; Poljanc K; Aiginger H; Georg D
Phys Med Biol; 2008 Apr; 53(7):1961-74. PubMed ID: 18354241
[TBL] [Abstract][Full Text] [Related]
4. The radiobiology of targeted radiotherapy.
Wheldon TE; O'Donoghue JA
Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
Lucas S; Feron O; Gallez B; Masereel B; Michiels C; Vander Borght T
Comput Math Methods Med; 2015; 2015():284360. PubMed ID: 26136812
[TBL] [Abstract][Full Text] [Related]
6. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
Bardiès M; Chatal JF
Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573
[TBL] [Abstract][Full Text] [Related]
7. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
[TBL] [Abstract][Full Text] [Related]
8. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
[TBL] [Abstract][Full Text] [Related]
9. Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
Hindié E; Zanotti-Fregonara P; Quinto MA; Morgat C; Champion C
J Nucl Med; 2016 May; 57(5):759-64. PubMed ID: 26912441
[TBL] [Abstract][Full Text] [Related]
10. Absorbed fractions for electrons and beta particles in spheres of various sizes.
Siegel JA; Stabin MG
J Nucl Med; 1994 Jan; 35(1):152-6. PubMed ID: 8271037
[TBL] [Abstract][Full Text] [Related]
11. Discrete beta dose kernel matrices for nuclides applied in targeted radionuclide therapy (TRT) calculated with MCNP5.
Reiner D; Blaickner M; Rattay F
Med Phys; 2009 Nov; 36(11):4890-6. PubMed ID: 19994497
[TBL] [Abstract][Full Text] [Related]
12. Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics, (125)Sn-(177)Lu is superior to (90)Y-(177)Lu in peptide receptor radiotherapy.
Walrand S; Hanin FX; Pauwels S; Jamar F
Phys Med Biol; 2012 Jul; 57(13):4263-75. PubMed ID: 22705627
[TBL] [Abstract][Full Text] [Related]
13. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy.
Prestwich WV; Nunes J; Kwok CS
J Nucl Med; 1989 Jun; 30(6):1036-46. PubMed ID: 2738686
[TBL] [Abstract][Full Text] [Related]
14. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.
Webb S; Nahum AE
Phys Med Biol; 1993 Jun; 38(6):653-66. PubMed ID: 8346278
[TBL] [Abstract][Full Text] [Related]
15. Low-energy electron emitters for targeted radiotherapy of small tumours.
Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
[TBL] [Abstract][Full Text] [Related]
16. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
Pasciak AS; Bourgeois AC; Bradley YC
J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
18. Alpha-particle microdosimetry.
Chouin N; Bardies M
Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
[TBL] [Abstract][Full Text] [Related]
19. Some characteristics of tumour control probability for heterogeneous tumours.
Ebert MA; Hoban PW
Phys Med Biol; 1996 Oct; 41(10):2125-33. PubMed ID: 8912385
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling.
Wright P; Muren LP; Høyer M; Malinen E
Acta Oncol; 2010 Oct; 49(7):1045-51. PubMed ID: 20831494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
